PubMed1996
The controversy concerning breast implants has led to a profound change in our surgical practice. Four years after the moratorium suspending the use of silicone implants, the situation still remains confused. Polyurethane implants, incriminated as being dangerous at the start of the anti-implant campaign, were cleared by the FDA in 1995, but have not been re-released onto the market. Silicone implants, the subject of a great many international studies on carcinogenicity and immunological risks which failed to confirm these risks, are now being used again throughout the world except in the USA, Canada and France. Hydrogel implants, victims of the bad reputation of the other implants, were suspended for dubious insurance reasons concerning the French Huriet law, although they satisfy the clinical and laboratory criteria required for breast implants. Only normal saline implants are currently used in France, although their safety is only relative, as the reoperation rate for deflation is not negligible. In our opinion, the Cronin type of bladder implant is obsolete and the new available technologies must be used, although they raise an economic problem following the overpublicized silicone implant catastrophe.